Clinical trials
Phase 3 Recurrence trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Fudan University | 2 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2 |
| The First Affiliated Hospital of Soochow University | 2 |
| Turku University Hospital | 2 |
| Beijing Friendship Hospital | 1 |
| Bubba Nicholson | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Central Texas Neurology Consultants | 1 |
| Chinese Medical Association | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 40 |
| Carcinoma, Hepatocellular | 4 |
| Lymphoma, Non-Hodgkin | 2 |
| Multiple Sclerosis | 2 |
| Rectal Fistula | 2 |
| Urinary Bladder Neoplasms | 2 |
| Anus Diseases | 1 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Condylomata Acuminata | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.